About
BenchSci uses advanced AI to accelerate biomedical research by helping scientists quickly identify and procure the right antibodies. Their cloud-based platform is adopted by 16 of the top 20 pharma companies and more than 4,300 research institutions worldwide, cutting the time to discovery and improving data quality. By combining machine learning with a curated reagent database, BenchSci delivers actionable insights that reduce experimental waste and speed drug development. The company’s remote-first culture, industry accolades, and commitment to employee well-being position it as a leading innovator in the intersection of life science and AI.
